Protective alleles and modifier variants in human health and disease (Q38616791)

4 September 2017

title

Protective alleles and modifier variants in human health and disease (English)

1 reference

4 September 2017

Andrew R Harper

1

0 references

Eric J. Topol

series ordinal

3

object named as

Eric J Topol

1 reference

4 September 2017

Shalini Nayee

2

1 reference

4 September 2017

publication date

27 October 2015

1 reference

4 September 2017

published in

Nature Reviews Genetics

1 reference

4 September 2017

volume

16

1 reference

4 September 2017

issue

12

1 reference

4 September 2017

page(s)

689-701

1 reference

4 September 2017

cites work

The genetics of health

1 reference

Life extension factor klotho enhances cognition

21 January 2018

1 reference

Clinical development success rates for investigational drugs

21 January 2018

1 reference

The support of human genetic evidence for approved drug indications

21 January 2018

1 reference

Validating therapeutic targets through human genetics

21 January 2018

1 reference

Resistance to HIV Infection

21 January 2018

1 reference

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

Maraviroc for previously treated patients with R5 HIV-1 infection

21 January 2018

1 reference

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

21 January 2018

1 reference

Genome editing-based HIV therapies

21 January 2018

1 reference

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

21 January 2018

1 reference

A century of cholesterol and coronaries: from plaques to genes to statins

21 January 2018

1 reference

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

21 January 2018

1 reference

A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.

21 January 2018

1 reference

Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability

21 January 2018

1 reference

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis

21 January 2018

1 reference

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

21 January 2018

1 reference

PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses

21 January 2018

1 reference

The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population

21 January 2018

1 reference

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

21 January 2018

1 reference

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events

21 January 2018

1 reference

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

21 January 2018

1 reference

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

21 January 2018

1 reference

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

21 January 2018

1 reference

Romosozumab in postmenopausal women with low bone mineral density.

21 January 2018

1 reference

Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection.

21 January 2018

1 reference

Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.

21 January 2018

1 reference

Variation at HLA-DRB1 is associated with resistance to enteric fever

21 January 2018

1 reference

Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study

21 January 2018

1 reference

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease

21 January 2018

1 reference

Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease

21 January 2018

1 reference

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis.

21 January 2018

1 reference

A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci

21 January 2018

1 reference

The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis

21 January 2018

1 reference

Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses

21 January 2018

1 reference

Genetic insights into common pathways and complex relationships among immune-mediated diseases

21 January 2018

1 reference

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

21 January 2018

1 reference

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes

21 January 2018

1 reference

The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans

21 January 2018

1 reference

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

21 January 2018

1 reference

Distribution and medical impact of loss-of-function variants in the Finnish founder population

21 January 2018

1 reference

The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation

21 January 2018

1 reference

Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein

21 January 2018

1 reference

Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population

21 January 2018

1 reference

Rarity of the Alzheimer disease-protective APP A673T variant in the United States

21 January 2018

1 reference

Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseases.

21 January 2018

1 reference

Absence of A673T variant in APP gene indicates an alternative protective mechanism contributing to longevity in Chinese individuals.

21 January 2018

1 reference

What does it take to produce a breakthrough drug?

21 January 2018

1 reference

BACE1 inhibitor drugs in clinical trials for Alzheimer's disease

21 January 2018

1 reference

Inactivating mutations in NPC1L1 and protection from coronary heart disease

21 January 2018

1 reference

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

21 January 2018

1 reference

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease

21 January 2018

1 reference

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

21 January 2018

1 reference

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.

21 January 2018

1 reference

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

21 January 2018

1 reference

Common variants associated with plasma triglycerides and risk for coronary artery disease

21 January 2018

1 reference

Loss-of-function mutations in SLC30A8 protect against type 2 diabetes

21 January 2018

1 reference

Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.

21 January 2018

1 reference

Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity

21 January 2018

1 reference

Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants

21 January 2018

1 reference

The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance

21 January 2018

1 reference

A systematic survey of loss-of-function variants in human protein-coding genes

21 January 2018

1 reference

Identification of a large set of rare complete human knockouts

21 January 2018

1 reference

Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1

21 January 2018

1 reference

Genetic ancestry and risk of breast cancer among U.S. Latinas

21 January 2018

1 reference

Medical research: Missing patients

21 January 2018

1 reference

Individualized medicine from prewomb to tomb

21 January 2018

1 reference

A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease

21 January 2018

1 reference

Class II HLA interactions modulate genetic risk for multiple sclerosis

21 January 2018

1 reference

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

21 January 2018

1 reference

GENCODE: the reference human genome annotation for The ENCODE Project

21 January 2018

1 reference

Association of human aging with a functional variant of klotho

21 January 2018

1 reference

Somatic mosaicism: implications for disease and transmission genetics

21 January 2018

1 reference

Chromothripsis: chromosomes in crisis

21 January 2018

1 reference

Chromothriptic cure of WHIM syndrome

21 January 2018

1 reference

Genetic compensation induced by deleterious mutations but not gene knockdowns.

21 January 2018

1 reference

Translational genomics. Clues from the resilient

21 January 2018

1 reference

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

21 January 2018

1 reference

Phenome-wide association studies (PheWASs) for functional variants

21 January 2018

1 reference

Cholesterol, racial variation and targeted medicines

21 January 2018

1 reference

Genetics of human gene expression: mapping DNA variants that influence gene expression

21 January 2018

1 reference

Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations

21 January 2018

1 reference

Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia

21 January 2018

1 reference

A de novo gain-of-function mutation in SCN11A causes loss of pain perception

21 January 2018

1 reference

The phenotype of congenital insensitivity to pain due to the NaV1.9 variant p.L811P.

21 January 2018

1 reference

A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density

21 January 2018

1 reference

Myostatin mutation associated with gross muscle hypertrophy in a child

21 January 2018

1 reference

Genetic variants associated with Lp(a) lipoprotein level and coronary disease

21 January 2018

1 reference

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

21 January 2018

1 reference

Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

21 January 2018

1 reference

TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits

21 January 2018

1 reference

The hunt for missing genes

21 January 2018

1 reference

The cost of drug development

31 March 2020

1 reference

Biopharmaceutical benchmarks 2014

31 March 2020

1 reference

Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE)

31 March 2020

1 reference

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

31 March 2020

1 reference

Phenotypic extremes in rare variant study designs

31 March 2020

1 reference

Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers

31 March 2020

1 reference

Segregation of a missense mutation in the amyloid beta-protein precursor gene with familial Alzheimer's disease.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRG4017

1 reference

Dimensions Publication ID

4 September 2017

1009514457

0 references

1 reference